Evaluation of Ventricular Remodeling and Prognosis in Patients with Aortic Stenosis Who Underwent Surgical or Percutaneous Transcatheter Aortic Valve Replacement

Overview

Journal Braz J Cardiovasc Surg

Specialty Cardiology & Vascular Diseases

Date 2022 Mar 4

PMID 35244379

Authors

Rodrigo de Moura Joaquim

Tiago Ghislandi Nuernberg

Tammuz Fattah

Roberto Leo da Silva

Affiliations

Soon will be listed here.

Abstract

Introduction: Aortic stenosis is the most common heart valve disease in the world, and patients that present with symptoms have a high mortality rate. Aortic valve replacement has the objective of promote left ventricular remodeling, reduce symptoms, and increase overall survival. The objective of this study is to evaluate reverse remodeling of the left ventricle in patients with severe and symptomatic aortic stenosis who underwent surgical or percutaneous transcatheter aortic valve replacement.

Methods: This is a longitudinal, prospective, non-concurrent, non-randomized unicentric study with patients who underwent aortic valve replacement. Echocardiogram was performed before and after replacement procedure to evaluate several remodeling indexes.

Results: Of 91 patients, 77 (84.6%) underwent surgical aortic valve replacement, and 14 (15.4%) underwent percutaneous transcatheter aortic valve replacement. Mean age was 68,96±11,98 years, and most patients were male. Remodeling evaluation revealed that patients who decreased left ventricular index mass (53% vs. 38.9%; P=0,019) and those who reduced the mass/volume ratio (30.4% vs. 68.9%; P<0,001) presented with positive left ventricular remodeling. No endpoint difference was found in those with positive remodeling.

Conclusion: Regarding the left ventricular remodeling in patients with severe and symptomatic aortic valve stenosis who underwent percutaneous transcatheter or surgical valve replacement, there is a positive increment in remodeling, however it remains in concentric hypertrophic shape. Implication of these findings remains uncertain and to be studied in large dedicated trials with clinical endpoints.

Citing Articles

A wolf in sheep's clothing-aortic stenosis and cardiac amyloidosis: "RAISE"ing awareness in clinical practice.

Sabbour H, Al-Humood K, Al Taha Z, Romany I, Haddadin H, Mohty D Front Cardiovasc Med. 2024; 11:1323023.

PMID: 38464842 PMC: 10921426. DOI: 10.3389/fcvm.2024.1323023.

The Association Between Ascending Aortic and Left Ventricular Dimensions in Patients After Aortic Valve Replacement.

Schusterova I, Artemiou P, Gasparovic I, Poruban T, Barbierik Vachalcova M, Sieradzka K Braz J Cardiovasc Surg. 2024; 39(2):e20230221.

PMID: 38426718 PMC: 10903743. DOI: 10.21470/1678-9741-2023-0221.

References

Rogers T, Waksman R . Role of CMR in TAVR. JACC Cardiovasc Imaging. 2016; 9(5):593-602. DOI: 10.1016/j.jcmg.2016.01.011. View

Al Musa T, Plein S, Greenwood J . The role of cardiovascular magnetic resonance in the assessment of severe aortic stenosis and in post-procedural evaluation following transcatheter aortic valve implantation and surgical aortic valve replacement. Quant Imaging Med Surg. 2016; 6(3):259-73. PMC: 4929281. DOI: 10.21037/qims.2016.06.05. View

Fairbairn T, Steadman C, Mather A, Motwani M, Blackman D, Plein S . Assessment of valve haemodynamics, reverse ventricular remodelling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement: a cardiovascular magnetic resonance study. Heart. 2013; 99(16):1185-91. PMC: 3747520. DOI: 10.1136/heartjnl-2013-303927. View

Ngo A, Hassager C, Horsted Thyregod H, Sondergaard L, Olsen P, Steinbruchel D . Differences in left ventricular remodelling in patients with aortic stenosis treated with transcatheter aortic valve replacement with corevalve prostheses compared to surgery with porcine or bovine biological prostheses. Eur Heart J Cardiovasc Imaging. 2017; 19(1):39-46. DOI: 10.1093/ehjci/jew321. View

La Manna A, Sanfilippo A, Capodanno D, Salemi A, Cadoni A, Cascone I . Left ventricular reverse remodeling after transcatheter aortic valve implantation: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2013; 15:39. PMC: 3673841. DOI: 10.1186/1532-429X-15-39. View

Varshney A, Manandhar P, Vemulapalli S, Kirtane A, Mathew V, Shah B . Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2019; 12(4):373-382. PMC: 6822896. DOI: 10.1016/j.jcin.2018.11.013. View

Gonzales H, Douglas P, Pibarot P, Hahn R, Khalique O, Jaber W . Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries. JACC Cardiovasc Interv. 2020; 13(11):1329-1339. DOI: 10.1016/j.jcin.2020.03.011. View

Treibel T, Badiani S, Lloyd G, Moon J . Multimodality Imaging Markers of Adverse Myocardial Remodeling in Aortic Stenosis. JACC Cardiovasc Imaging. 2019; 12(8 Pt 1):1532-1548. DOI: 10.1016/j.jcmg.2019.02.034. View

Tarasoutchi F, Montera M, Ramos A, Sampaio R, Rosa V, Augusto Duenhas Accorsi T . . Arq Bras Cardiol. 2018; 109(6 suppl 2):1-34. DOI: 10.5935/abc.20180007. View

10.

Leon M, Smith C, Mack M, Makkar R, Svensson L, Kodali S . Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016; 374(17):1609-20. DOI: 10.1056/NEJMoa1514616. View

11.

Chau K, Douglas P, Pibarot P, Hahn R, Khalique O, Jaber W . Regression of Left Ventricular Mass After Transcatheter Aortic Valve Replacement: The PARTNER Trials and Registries. J Am Coll Cardiol. 2020; 75(19):2446-2458. DOI: 10.1016/j.jacc.2020.03.042. View

12.

Mack M, Leon M, Thourani V, Makkar R, Kodali S, Russo M . Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019; 380(18):1695-1705. DOI: 10.1056/NEJMoa1814052. View

13.

Horsted Thyregod H, Steinbruchel D, Ihlemann N, Nissen H, Kjeldsen B, Petursson P . Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. J Am Coll Cardiol. 2015; 65(20):2184-94. DOI: 10.1016/j.jacc.2015.03.014. View

14.

Adams D, Popma J, Reardon M, Yakubov S, Coselli J, Deeb G . Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014; 370(19):1790-8. DOI: 10.1056/NEJMoa1400590. View

15.

Biederman R, Magovern J, Grant S, Williams R, Yamrozik J, Vido D . LV reverse remodeling imparted by aortic valve replacement for severe aortic stenosis; is it durable? A cardiovascular MRI study sponsored by the American Heart Association. J Cardiothorac Surg. 2011; 6:53. PMC: 3094375. DOI: 10.1186/1749-8090-6-53. View

16.

Lamb H, Beyerbacht H, de Roos A, van der Laarse A, Vliegen H, Leujes F . Left ventricular remodeling early after aortic valve replacement: differential effects on diastolic function in aortic valve stenosis and aortic regurgitation. J Am Coll Cardiol. 2002; 40(12):2182-8. DOI: 10.1016/s0735-1097(02)02604-9. View

17.

Reardon M, Van Mieghem N, Popma J, Kleiman N, Sondergaard L, Mumtaz M . Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017; 376(14):1321-1331. DOI: 10.1056/NEJMoa1700456. View

18.

Smith C, Leon M, Mack M, Miller D, Moses J, Svensson L . Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011; 364(23):2187-98. DOI: 10.1056/NEJMoa1103510. View

19.

Nishimura R, Otto C, Bonow R, Carabello B, Erwin 3rd J, Fleisher L . 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017; 70(2):252-289. DOI: 10.1016/j.jacc.2017.03.011. View